Tissue-resident memory T cells (T RM ) are noncirculating immune cells that contribute to the first line of local defense against reinfections. Their location at hotspots of pathogen encounter frequently exposes T RM to tissue damage. This history of danger-signal exposure is an important aspect of T RM -mediated immunity that has been overlooked so far. RNA profiling revealed that T RM from liver and small intestine express P2RX7, a damage/danger-associated molecular pattern (DAMP) receptor that is triggered by extracellular nucleotides (ATP, NAD + ). We confirmed that P2RX7 protein was expressed in CD8 + T RM but not in circulating T cells (T CIRC ) across different infection models. Tissue damage induced during routine isolation of liver lymphocytes led to P2RX7 activation and resulted in selective cell death of T RM . P2RX7 activation in vivo by exogenous NAD + led to a specific depletion of T RM while retaining T CIRC . The effect was absent in P2RX7-deficient mice and after P2RX7 blockade. TCR triggering down-regulated P2RX7 expression and made T RM resistant to NAD-induced cell death. Physiological triggering of P2RX7 by sterile tissue damage during acetaminophen-induced liver injury led to a loss of previously acquired pathogen-specific local T RM in wild-type but not in P2RX7 KO T cells. Our results highlight P2RX7-mediated signaling as a critical pathway for the regulation of T RM maintenance. Extracellular nucleotides released during infection and tissue damage could deplete T RM locally and free niches for new and infection-relevant specificities. This suggests that the recognition of tissue damage promotes persistence of antigen-specific over bystander T RM in the tissue niche.
INTRODUCTION
Tissue-resident memory T cells (T RM ) form a crucial first line of defense against local infection and invading pathogens. They are specialized memory T cells that do not recirculate through blood and lymph but are permanently located in an organ. T RM have been detected in barrier tissues such as the intestine, skin, and lung; in internal organs such as brain and liver; and in secondary lymphoid organs. Because of their location at pathogen entry points and their ability to unleash immediate effector functions after activation, T RM confer superior protection against local infections compared with circulating T cells (T CIRC ) (1) (2) (3) (4) . Upon recognition of their cognate antigen, T RM initiate a tissue-wide state of alert by recruiting other immune cells to the site of infection (4) (5) (6) .
Their location in the front line of the immune system positions T RM at hotspots of pathogen encounter. Therefore, T RM are frequently exposed to tissue damage and inflammatory events. In many cases, T RM will not encounter their cognate pathogen but will receive nonspecific signals of inflammation and tissue damage. This history of local inflammation and tissue damage is an important aspect of T RM homeostasis that has not been studied so far.
Pathogen encounter, inflammation, and tissue damage lead to the release of danger signals. These so-called pathogen-or danger-associated molecular patterns (DAMPs) comprise exogenous pathogen-derived molecules (e.g., lipopolysaccharide, double-stranded RNA) as well as nonmicrobial endogenous signals derived from stressed and dying cells that are released during infection and inflammation and during tissue damage by toxins or ischemia (7) . The tissue damage-associated DAMPs mainly comprise intracellular and intranuclear molecules such as HMGB1, S100 proteins, DNA, and RNA, as well as purine metabolites that are released by dying cells (8) . DAMPs are recognized by a large array of pattern recognition receptors (PRRs), including Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), AIM2-like receptors (ALRs), NOD (nucleotide-binding and oligomerization domain)-like receptors (NLRs), and purinergic receptors (P2XRs and P2YRs). Triggering of these receptors on innate immune cells initiates a tissue-wide alert and induces the production of proinflammatory cytokines and other signals that recruit and activate additional innate and adaptive immune cells. However, T cells can also sense DAMPs directly. Triggering of TLR2, TLR7, and NOD1 on T cells provide costimulatory signals for T cell activation (9) (10) (11) (12) (13) . Similarly, activation of the purinergic receptor P2RX1, P2RX4, or P2RX7 by extracellular adenosine triphosphate (ATP) costimulates T cell activation (14, 15) and recently has been shown to play a role in the generation of memory CD8 + T cells (16) . The RLR LGP2 improves survival of activated CD8 + T cells during viral infection (17) . However, triggering of PRRs can also limit T cell responses. NLRX activation inhibits proliferation of T cells (18) , and activation of the cytosolic DNA detector STING after T cell receptor (TCR) triggering as well as prolonged triggering of the purinergic receptor P2RX7 induces cell death in T cells (15, 19) . Most of these studies focused on T CIRC . Despite the localization of T RM at hotspots of pathogen encounter, it is currently unknown how T RM respond to danger signals.
Using transcriptome profiling of lymphocytic choriomeningitis virus (LCMV)-specific CD8 + T cells from liver, spleen, and small intestine, we analyzed which sensors for danger signals are specifically expressed by T RM and identified the tissue damage receptor P2RX7 to be highly up-regulated in T RM . P2RX7 is an ion channel that responds to extracellular ATP and NAD + (nicotinamide adenine dinucleotide). The concentration of NAD + and ATP is high intracellularly (100 M to 2 mM) but in the low nanomolar range in the interstitium of healthy tissues (20, 21) . The local concentration of extracellular ATP and NAD + is strongly increased under pathological conditions and during tissue damage, tumor development, and inflammation, as both nucleotides are released into the extracellular space (22) (23) (24) . Necrotic cells can release their intracellular contents, and apoptotic or stressed cells in inflammatory settings can secrete NAD + and ATP actively via pannexin and connexin channels (25, 26) . The function of P2RX7 has been previously studied in detail in natural killer T (NKT) cells and follicular and regulatory T cells, which also express P2RX7. Triggering of P2RX7 by high levels of ATP or NAD + induces massive efflux of K + ions and the formation of a P2RX7 pore, resulting in cell death of the triggered T cell (15, 27, 28) . Using experimental infection models as well as sterile induction of tissue damage by acetaminophen, we demonstrate that P2RX7 activation in vivo leads to a specific depletion of T RM , whereas T CIRC are maintained. Activation of T RM by TCR ligation induced a marked downregulation of P2RX7 and resistance to P2RX7-mediated cell death, whereas interleukin-12 (IL-12) up-regulated P2RX7, suggesting that in local infections, the presence of antigen and inflammatory cytokines modulate T RM persistence.
These results describe P2RX7-mediated signaling as a critical pathway for the regulation of T RM maintenance. Extracellular nucleotides released during inflammation and tissue injury could deplete T RM locally and free niches for new specificities. Down-regulation of P2RX7 by TCR stimulation suggests that the pathway promotes persistence of antigen-specific cells over activated bystander cells in the tissue niche.
RESULTS

The tissue damage receptor P2RX7 is selectively expressed on CD8
+ T RM To analyze which DAMPs T RM could respond to, we used previously published RNA-sequencing (RNA-seq) data of tissue-resident as well as circulating LCMV-specific memory CD8 + T cells from liver, small intestine, and spleen (29) . T RM were defined by CD69 expression and absence of CD62L and expressed T RM -associated molecules such as CXCR6 and CD103 or the transcription factor Hobit (figs. S1 and S2). Of the 47 selected PRRs, 7 were differentially expressed between the memory T cell subsets. AIM2, P2RX7, and P2RY10 were highly expressed in T RM from liver and small intestine. Whereas AIM2 and P2RY10 were expressed at intermediate or high levels in T CIRC [naïve T cells (T N ), central memory T cells (T CM ), and effector memory T cells (T EM )], P2RX7 was lowly expressed (Fig. 1A) . The high expression of P2RX7 on T RM compared with T CIRC (T CM and T EM ) was confirmed on pathogen-specific T cells 30+ days after infection (Fig. 1, B and C, and fig. S3 , A and B). P2RX7 was highly expressed not only on T RM in the small intestine and liver but also on T RM in the lung, bone marrow (BM), kidney, and salivary gland, suggesting that P2RX7 expression is a universal feature of T RM . The danger receptor P2RX7 can be activated via two different routes. Extracellular ATP triggers transient activation of P2RX7, resulting in the opening of a cation channel. Extracellular NAD + induces constitutive activation of P2RX7 through the ectoenzyme ARTC2.2, which catalyzes adenosine diphosphate (ADP) ribosylation of P2RX7 and induces constitutive P2RX7 activation. Compared with T CIRC , T RM expressed higher levels not only of P2RX7 but also of ARTC2.2 ( Fig. 1D and figs. S3C and S4), which suggests that these memory cells are more susceptible to NAD + -mediated activation of P2RX7 compared with T CIRC . Local concentrations of extracellular NAD + and ATP are also influenced by enzymatic activity of cell membrane proteins. The two ectoenzymes CD38 and CD39 are known to drive the degradation of extracellular NAD + and ATP. CD39 hydrolyzes ATP to ADP, and CD38 catalyzes the formation of adenosine diphosphate ribose and nicotinamide from NAD + (26, 30) . The high expression of both ectoenzymes on T RM compared with T CIRC (Fig. 1E and fig. S4 ) might provide a regulatory mechanism that limits the duration of the activating signal of extracellular nucleotides on T RM . Previously published transcriptional profiles (29) fig. S5A) , and more than 80% of the T cells were of donor origin 8 to 12 weeks after the generation of the mixed BM chimeras. The distribution of T CIRC and T RM was equal in the WT and P2RX7 KO compartment ( fig.S5A ), suggesting that P2RX7 does not influence the development of CD8 + T cells. To investigate the CD8 + T cell response after antigen challenge, we infected WT and P2RX7 KO mice as well as WT-P2RX7 KO mixed BM chimeras with LCMV and analyzed the effector response at day 8 after infection. In both experimental setups, the effector response of LCMV-specific WT and P2RX7 KO CD8 + T cells was of similar magnitude and displayed the same short-lived effector cell/memory precursor effector cell phenotype ( fig. S5 , B to D). These findings were expected as P2RX7 expression was low or absent on WT effector CD8 + T cells in the blood ( fig.S5E ). Similarly, analysis of LCMV-infected mice at day 30+ after infection showed that the memory response of WT and P2RX7 KO CD8 + T cells was of similar size and composition (Fig. 2, A and B) . The frequency of T RM and T CIRC subsets (T CM and T EM ) was comparable between WT and P2RX7 KO mice in all analyzed organs. The WT and P2RX7 KO compartments of mixed BM chimeras generated similar frequencies of pathogen-specific T RM at day 30+ after infection with LCMV or Listeria monocytogenes-ovalbumin (LM-OVA) ( Fig. 2C  and fig. S6 ), and the expression of ARTC2.2 and CD38 was not influenced by P2RX7 deficiency ( fig. S7 ). These data demonstrate that P2RX7 does not play a role in the generation of CD8 + T cells and is dispensable for the generation of T RM and other CD8 + T cell subsets after infection.
P2RX7 activation by NAD
+ induces cell death of T RM but not T CIRC P2RX7 is activated via the extracellular nucleotides ATP and NAD + . To investigate how P2RX7 triggering influences T RM maintenance, we treated T RM isolated from the small intestine or T CIRC from the spleen in vitro with increasing concentrations of NAD + . CD8 + T RM but not T CIRC died after adding NAD + in a dose-dependent manner (Fig. 3, A and B ). In contrast, T RM isolated from P2RX7 KO mice were insensitive to NAD + treatment (Fig. 3 , C and D), suggesting that NAD + -induced cell death of T RM is P2RX7 dependent. Treatment with inhibitors of P2RX7 or the P2RX7-activating ectoenzyme ARTC2.2 confirmed these findings (Fig. 3E ). Direct inhibition of P2RX7 activation (E) At day 30+ after LCMV infection, LCMV-specific (GP33-tetramer) CD8 + T cells were analyzed (n = 4/5).
by the P2RX7 inhibitors A438079 or KN-62 as well as inhibition of ARTC2.2 with nanobody rescued T RM survival after NAD + treatment, whereas no effect on T CIRC was observed (Fig. 3E ). Elevated concentrations of 1 to 10 M extracellular NAD + have been detected in inflamed tissues in vivo (22) , suggesting that during inflammation and tissue damage, T RM can succumb to NAD + -induced cell death.
P2RX7 expression is modulated by TCR activation and cytokine signals
During infection, inflammation, and tissue damage, the local microenvironment of T RM changes quickly, with alterations in the cellular composition and the presence of antigen and inflammatory cytokines. These signals could modulate the expression of P2RX7 and the ability of CD8 + T cells to respond to extracellular ATP and NAD + . Whereas type I interferons (IFNs) did not change P2RX7 expression, IL-12 up-regulated P2RX7 on T RM (Fig. 4A ). ARTC2.2 expression was unchanged ( fig. S8A ). In addition, during priming of naïve CD8 + T cells, IL-12 induced P2RX7 expression at similar levels to retinoic acid (RA) ( fig. S8B ), which is known as a P2RX7-inducing agent (31) . This suggests that during inflammation IL-12 may sensitize T RM to cell death induced by extracellular nucleotides through up-regulation of P2RX7. The cytokines IL-33, tumor necrosis factor- (TNF-), and transforming growth factor- (TGF-) associated with T RM differentiation and maintenance did not induce P2RX7 and did not substantially influence P2RX7 maintenance ( fig.  S8 , B and C). Last, we analyzed how recognition of antigen and TCRmediated activation influenced T RM homeostasis. TCR triggering reduced P2RX7 expression on T RM (Fig. 4, B and C, and fig. S8D ) and made them less sensitive to NAD-induced cell death (Fig. 4D and fig. S8 , E and F). These data suggest that TCR triggering may selectively rescue antigen-specific over nonspecific T RM from P2RX7-driven cell death induced by tissue damage.
P2RX7 activation depletes T RM but not T CIRC in vivo
To study the impact of P2RX7 activation in vivo, we injected mice with NAD + and quantified CD8 + T cell subsets in liver, BM, and small intestine intraepithelial lymphocytes (SI IEL) 24 hours after injection. In both liver and BM, we observed a decreased frequency of CD8 + T RM in NAD (Fig. 5C ). Similar results were obtained for LCMV-specific memory T cells. The frequencies of LCMV-specific T RM in the SI IEL and liver were reduced by 18-fold (SI IEL) or 6-fold (liver) (Fig. 5, D and E) at 24 hours after NAD + injection. In contrast, the frequency of LCMV-specific T EM cells in the liver remained unchanged in NAD + -injected compared to the PBS-injected control mice (Fig. 5E ). To investigate whether the NAD + -induced depletion of T RM was dependent on T RM -expressed P2RX7, we generated mixed BM chimeras. As described in Fig. 2 , no defects in the generation of T RM were observed in the absence of P2RX7. WT and P2RX7 KO compartments contributed equally to T EM and T RM in liver, BM, kidney, spleen, and SI IEL in the PBS-injected control mice ( Fig. 5F and fig. S9 ). NAD + injection led to the loss of WT T RM . In contrast, P2RX7 KO T RM as well as WT and P2RX7 KO T EM were maintained after NAD + injection ( Fig. 5F and fig. S9 ). We conclude that the elevated concentration of extracellular NAD + during tissue injury could induce NAD + -driven activation of P2RX7 and regulate T RM maintenance during tissue damage. These data also demonstrate the potential of NAD + injections as a tool to selectively deplete T RM while leaving T CIRC responses intact.
Tissue damage depletes T RM but not T CIRC in a P2RX7-dependent manner
To investigate the effect of tissue damage on T cell subsets, we used the circumstance that the disaggregation of organs is often a prerequisite for the isolation of T cells from these locations. T RM or T CIRC subsets were isolated from the liver, which involves mashing of the tissue and therefore exposes T cells within the liver to tissue damage. The isolated subsets were cultured for 6 hours at 37°C. Whereas T CIRC (T CM and T EM ) were more than 90% viable after 6 hours of culture, less than 40% of the liver T RM remained viable during this culture period (Fig. 6A) . To inhibit activation of P2RX7 by extracellular NAD + during tissue preparation, mice were injected with ARTC2.2-blocking nanobody before sacrifice, which has previously been shown to enhance viability of P2RX7-expressing lymphocytes (32-34) . The injection of anti-ARTC2.2 nanobody s+16a improved liver T RM viability during culture to the same level of T CM and T EM (Fig. 6A) . CD8 + T RM isolated from SI IEL with minimal mechanical destruction did not demonstrate increased cell death ( fig. S10A ). These data suggest that the short-term tissue damage induced during the mashing of the liver is sufficient to induce NAD + -induced cell death of T RM . To test the survival of T RM after induction of tissue damage in vivo, we treated LCMV-immune mice (30+ days after LCMV infection) with acetaminophen to induce acute sterile liver injury. In acetaminophen-treated mice, T RM were underrepresented in LCMVspecific CD8 + T cells in the liver compared to PBS-treated controls 24 hours after liver injury induction (Fig. 6B) . The tissue damageinduced loss of T RM was P2RX7 specific, because no reduction in the T RM frequency was observed in P2RX7 KO mice after liver injury induction (Fig. 6B) . Similar effects were observed in a competitive setting of acetaminophen-induced liver injury in LCMV-immune mixed (WT-P2RX7 KO) BM chimeras (Fig. 6C) as well as in mice that received cotransfer of TCR transgenic WT and P2RX7 KO CD8 + T cells (Fig. 6D) . T RM depletion was restricted to the damaged organ, as reduction of WT T RM was observed in the liver (Fig. 6D) but not in the kidney (Fig. 6E) or spleen (fig. S10 , B and C) of acetaminophen-treated mice. The depletion of LCMV-specific T RM was long lasting, as 30+ days after liver injury induction, acetaminophen-treated mice still showed a reduction in liver T RM in the WT but not in the P2RX7 KO compartment (Fig. 6, C and D ). These data demonstrate that tissue damage during injury leads to a selective P2RX7-dependent depletion of T RM .
DISCUSSION
Our results introduce tissue damage as an important signal that regulates T RM maintenance. Inflammation and tissue damage during priming are important cofactors for the generation of T RM in tissues 
three experiments). Unpaired t test (B and D) and paired t test (E)
. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. (35, 36) . Activated CD8 + T cells get drawn into inflamed tissues and form T RM at the site of inflammation (prime-pull strategy) (3, 37) , and lung CD8 + T RM are preferentially formed at foci that show signs of previous tissue injury (36) . However, despite the location of T RM at hotspots of pathogen encounter, it was unknown how inflammation, tissue damage, and unrelated secondary infections affect preexisting T RM . We describe that T RM undergo cell death upon recognition of elevated levels of extracellular nucleotides via the DAMP receptor P2RX7 and that the recognition of tissue damage during sterile tissue injury deletes T RM in a P2RX7-dependent manner.
T RM are fast-reacting memory cells at the front line of the immune system. After recognition of cognate antigen, T RM initiate a tissuewide alert state and recruit other innate and adaptive immune cells that contribute to the protective function of T RM (4, 5, 38) . T RM express elevated levels of mRNA for effector molecules such as IFN- and granzyme B (39, 40) and are able to initiate these effector mechanisms ad hoc after activation. However, misguided or uncontrolled T RM responses lead to immunopathology in acute immune responses such as contact dermatitis as well as chronic autoimmune diseases (41) . Accordingly, T RM must be tightly controlled. The P2RX7-dependent deletion of T RM during sterile tissue damage could provide a negative feedback mechanism to prevent the unleashing of the T RM -dependent deployment of a proinflammatory immune response. Thereby, T RM -associated immunopathology is limited, and prompt regeneration fostered. The observed further increase of P2RX7 expression on T RM by the proinflammatory cytokine IL-12 suggests that, once inflammation is established, T RM are deleted after recognition of extracellular nucleotides in a P2RX7-dependent manner to quench further immune activation.
On the basis of our results on T RM susceptibility to sterile tissue damage in acetaminophen-induced liver injury, we hypothesize that local tissue damage and inflammation could also deplete preexisting T RM in the course of secondary infections. Because T RM are crucial for the protection of peripheral tissues, depletion of all T RM during infection-induced tissue damage would curtail T RM function. We demonstrate that TCR activation of T RM reduced P2RX7 expression and rescued T RM from cell death induced by extracellular nucleotides. Similar observations have been made for P2RX7 expression on follicular helper T cells (T FH ) in Peyer's patches (42) . This suggests that modulation of P2RX7 expression during infections could ensure that infection-relevant T RM are maintained. Extracellular nucleotides released during infection and tissue damage could deplete non-antigen-specific T RM locally and free niches for new and infection-activated specificities. It has been shown that in secondary infections, new T RM can be generated from naïve, effector, and circulating memory T cells (43) . As we have demonstrated, T CIRC have both lower expression of P2RX7 and are insensitive to tissue damage-induced cell death. This suggests that the recognition of tissue damage promotes persistence of antigen-specific over bystander T RM in the tissue niche. Because extracellular nucleotides are quickly metabolized, P2RX7-dependent deletion of T RM might be a very localized effect during infection of tissues. Susceptibility of T RM in this context might depend on their exact location as well as the tissue damage, lytic potential, and immunopathology inflicted by the pathogen; e.g., infection with LCMV WE causes substantial liver damage compared with LCMV Armstrong (44) . Analysis of the lungs after influenza infection shows distinct patches of regenerating tissue (36) , suggesting that within the parenchyma, tissue damage might influence T RM very locally. Accordingly, infections would not completely wipe out all of the T RM but just locally punch holes in the T RM repertoire at sites of tissue damage.
T RM are dependent on survival signals such as IL-15 in the tissues (45) . These signals are provided by accessory cells and might be a limiting factor for the dissemination of T RM in the tissue. In line with this, T RM in the skin are generated at the expense of dendritic epidermal  T cells (46) . With a series of consecutive unrelated infections and immunizations, however, recent data demonstrate that preexisting T RM in the skin are only minimally dislodged by newly generated T RM of different specificities (43) . In these experiments, no direct tissue damage or inflammation was induced at the site of primary T RM generation because "new" T RM are generated by immunizations/infections at different unrelated locations. Additionally, the lower P2RX7 mRNA levels in skin T RM compared with T RM in liver and small intestine (29) suggest that T RM maintenance during tissue damage in the skin might be differently regulated. Although we detect P2RX7 expression on most of the T RM in all tissues that we analyzed, T RM in other tissues or induced in other contexts might lack P2RX7 expression, as shown for a subset of influenzaspecific T RM in the lung (47) . T RM are underrepresented in lymphocyte preparations from nonlymphoid tissues (48) . It is possible that P2RX7-driven recognition of tissue damage during the isolation of lymphocytes contributes to poor T RM retrieval from peripheral tissues. Moreover, other P2RX7-expressing lymphocytes succumb to cell death after triggering of P2RX7 by extracellular NAD + , ATP, or tissue damage induced during the preparation of lymphocytes from the organs (31, 32, 42, (49) (50) (51) (52) . Inhibition of ARTC2.2 or P2RX7 activity is crucial for isolation of functional regulatory T cells (T regs ) as well as liver NKT cells and liver T RM and allows for in vivo survival of these P2RX7-and ARTC2.2-expressing cell populations after adoptive transfer (32) (33) (34) 53) . We found that the ectoenzymes CD38 and CD39, which limit the extracellular concentration of ATP and NAD + (54) , are highly expressed on T RM . Although T RM have counterregulatory mechanisms to reduce extracellular nucleotides, they are responsive to exogenous NAD + and tissue damage in vivo. CD38 and CD39 are also highly expressed by other P2RX7-expressing lymphocytes such as NKT cells, ILC1, and T regs (55, 56) , as well as T RM -like tumorinfiltrating CD8 + T cells (57) . This suggests that CD38 and CD39 function as a fail-safe to prevent inadvertent P2RX7 activation under homeostatic conditions. However, these nucleotide-degrading ectoenzymes do not appear to substantially reduce local concentrations of extracellular nucleotides in the event of tissue damage.
S C I E N C E I M M U N O L O G Y | R E S E A R C H A R T I C L E
The observed P2RX7-dependent depletion of T RM during tissue damage appears to be mainly mediated by NAD + -dependent constitutive P2RX7 activation via ARTC2.2, as ARTC2.2 inhibition in vivo nearly completely rescued cell death of T RM induced during tissue preparation. Additional studies will be needed to determine whether this or similar pathways also limit T RM maintenance in humans, in which ARTC2.2 is not functional. Recently, a role of P2RX7 in extracellular ATPdriven metabolic programming of CD8 + T cell memory has been demonstrated (16) . In this study, P2RX7 was described to affect the maintenance of long-lived memory CD8 + T cells, in contrast to our with acetaminophen, and 30+ days later, the frequencies of T RM in transferred WT and P2RX7 KO OT1 CD8 + T cells in the (D) liver and (E) kidney were quantified (n = 8 per group, one experiment). Mean ± SEM. Unpaired t test. *P ≤ 0.05, ***P ≤ 0.001.
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findings. Differences in genetic background or microbiota might have resulted in discrepancies. Additionally, we build on the results of Borges da Silva et al. (16) and demonstrate here that P2RX7 is highly up-regulated specifically on T RM CD8 + T cells in various tissues. P2RX7 expression has been demonstrated on other T cells that share a tissue-resident phenotype. Liver NKT cells, T regs , IEL, and T FH in the Peyer's patches of the small intestine express P2RX7 at high levels (31, 32, 42, (49) (50) (51) (52) . This implies that P2RX7-mediated recognition of tissue damage might be a feature that different types of tissueresident lymphocytes have in common. The high expression of P2RX7 and ARTC2.2 on liver ILCs suggests that at least ILC1 can respond to tissue damage similarly to NKT cells and T RM .
T RM are retained in the tissue in an alerted mode with elevated levels of effector molecules. Tight control of transcription, translation, and activation of T RM is needed to maintain tissue homeostasis. On the basis of our data, we propose an additional level of T RM regulation in the tissue. Recognition of tissue damage could equip T RM with a suicide mechanism to prevent excessive immunopathology.
MATERIALS AND METHODS
Study design
The main aim of this study was to assess the impact of danger signals and tissue damage on T RM CD8 + T cells in peripheral tissues. For the identification of danger signal receptors expressed on T RM , an existing RNA-seq dataset was used. The impact of the identified receptor P2RX7 on T RM generation and maintenance was analyzed with mouse models of LM-OVA and LCMV infection. Local tissue damage in the liver was studied using the acetaminophen-induced liver injury model. Detailed descriptions of the experimental parameters can be found below and in the figure captions. Sample sizes, number of experimental replicates, and statistical tests are indicated in the figure legends. /BoyJ × C57BL6/JRj (Ly5.1 × Ly5.2) recipients were irradiated (2 × 5 gray) and reconstituted with intravenous transfer of 2 × 10 7 BM cells. Mixed BM chimeras were used 8 to 16 weeks after reconstitution. Chimerism of lymphocytes was confirmed before usage. All mice were maintained under specific pathogen-free conditions. Animal experiments were conducted according to institutional and national guidelines.
Mice
Infections and other in vivo treatments
Mice were infected intraperitoneally with 1 × 10 5 plaque-forming units (PFU) of LCMV Armstrong and 1 × 10 5 PFU of rLCMV OVA (58) (provided by D. Merkler, University of Geneva) or by feeding of 2 × 10 9 colony-forming units of LM-OVA InlA M (provided by B. Sheridan, Stony Brook University) as described previously (59) . For some experiments, naïve CD8 + T cells (CD44 low and CD62L high ) of OT1 and P2RX7 KO OT1 mice were sorted and mixed in a ratio of 1:1, and 1 × 10 4 cells were transferred intravenously 1 day before infection. To trigger P2RX7 in vivo, we injected mice intravenously with 60 mg of NAD + (Sigma) in PBS or NaCl (pH 7) (200 l) or PBS as control. To induce liver injury, male mice were fasted overnight, mice were weighed, and acetaminophen (400 mg/kg) (Sigma) in PBS at a concentration of 15 mg/ml was injected intraperitoneally. Equivalent volumes of PBS were injected as a control. For detection of P2RX7, mice were injected intraperitoneally or intravenously with 50 g of ARTC2.2-blocking nanobody s+16a (BioLegend) 30 min before sacrifice (32) .
Tissue preparation
Single-cell suspension of spleen and liver was generated by passing organs over a 70-m cell strainer. IEL were prepared from the small intestine. After removal of residual fat tissue, Peyer's patches, and feces, pieces of small intestine were incubated for 30 min at 37°C in Hanks' balanced salt solution (Gibco) with 10% fetal calf serum (FCS), 5 mM EDTA, and 1 mM dithiothreitol and vortexed extensively. The IEL fraction was isolated by filtering over 70-m strainers. IEL-depleted intestine pieces, kidney, salivary glands, or lungs were chopped into small pieces and digested for 30 min at 37°C with collagenase type I (750 U/ml) (Invitrogen) and deoxyribonuclease I (0.31 mg/ml) (Roche, from bovine pancreas, grade II) in RPMI with 10% FCS, and singlecell suspensions were generated by filtering over 70-m strainers. The isolated lymphocytes were purified by density centrifugation on a 60%/40% Percoll gradient (GE Healthcare). CD8ab + T cells from IEL preparations contained >95% CD69 + /CD62L − cells. BM was isolated from tibia and femur by crushing the bones in PBS or flushing them with PBS and passing through a 70-m cell strainer. Contaminating erythrocytes were removed using red blood cell lysis buffer (155 mM NH 4 Cl, 10 mM KHCO 3 , and 0.1 mM EDTA). Probes) . After staining, cells were fixed with the eBioscience Transcription Factor Staining Buffer Set according to the manufacturer's specifications. Samples were acquired on an LSRFortessa flow cytometer (BD Biosciences), and data were analyzed using FlowJo (TreeStar). Cell sorting was performed using Aria III (BD Biosciences). Exemplary gating strategies are shown in fig. S1 .
Flow cytometry
In vitro treatments
Cells were cultured in vitro in RPMI (Gibco) supplemented with 10% FCS (Bodingo BV), penicillin (100 U/ml) (Sigma), streptomycin (100 g/ml) (Sigma), 2 mM l-glutamine (Sigma), and 55 M -mercaptoethanol (Gibco). To activate or inhibit P2RX7 NAD + (Sigma), we used A438079 (Abcam, 20 M), KN-62 (Abcam, 20 M), or anti-ARTC2 nanobody s+16a (BioLegend, 20 g/ml). Cells were stimulated with plate-bound anti-CD3 (clone 17A2, 5 g/ml) or SIINFEKL peptide (GenScript, 1 g/ml) and soluble anti-CD28 (clone PV-1, 1 g/ml, both a gift of L. Boon, Bioceros) with or without antigenpresenting cell-containing splenocytes and cultured in the presence of the following recombinant murine cytokines: IL-2, IL-7, and IL-15 (all from R&D Systems, 10 ng/ml), recombinant murine IFN- or IFN- (both from eBioscience, 10 ng/ml), IL-12, IL-33, TNF- (PeproTech, 10 ng/ml), recombinant human TGF- (PeproTech, 5 ng/ml), or all-trans RA (10 nM).
RNA-seq analysis
Previously published and normalized RNA-seq data (29) of sorted murine CD8 + T cell subsets after LCMV infection were analyzed for PRR-associated genes. Expression was detected for 47 manually selected PRR genes (table S1). Seven of the selected transcripts were differentially expressed (adjusted P < 0.05, fold change > 2, 8 reads per kilobase per million mapped reads) between T RM and T CIRC (T CM or T EM ) from liver, small intestine, and spleen.
Statistical analysis
Statistical analysis was carried out using GraphPad Prism. The test used is indicated in the figure legends. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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